UGN-101 for UTUC: Longitudinal Follow-Up of Multicenter Study

At the AUA 2024 Annual Meeting, Katie S. Murray, DO, of NYU Langone Urology and Bellevue Hospital, and Yair Lotan, MD, of UT Southwestern Medical Center, highlight Dr. Lotan’s recent multicenter study featuring longitudinal follow-up of UGN-101 for upper tract urothelial carcinoma.

View their continued comments on Developing and Validating AI Biomarkers to Predict Outcomes in BCG-Treated NMIBC.